Application no. and date | 16701276.4 (espacenet) (Federated) (European Patent Register), 20160120 | Patent/reg. no. and date | DK/EP 3247327, 20190807 | Publication date | 20171129 | Priority no. and date | US 201562106073 P, 20150121 | EP pub. no. and date |
EP 3247327 20171129 | Effective date | | Applicant/owner | Bayer Oy, Pansiontie 47
20210 Turku, FI | Applicant ref. no. | 1503650 | Inventor | PIHLAJA, Jyrki, Juntolantie 341
21530 Paimio, FI, Holmberg, Svante, Hirvikoirankatu 9 A 1
20900 Turku, FI, JUKARAINEN, Harri, Vadelmakatu 3
21620 Kuusisto, FI, VALO, Tuula, Taivassalonkatu 13
20740 Turku, FI, HONKA, Anu-Liisa, Michailowinkatu 2 A 8
20100 Turku, FI, HOLLAENDER, Jenny, Norrnäsintie 96
21600 Parainen, FI | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 9/00 (2006.01) , B29C 67/00 (2017.01) | Title | LÆGEMIDDELADMINISTRATIONSSYSTEM, DER OMFATTER EN NONSTEROID ANTIINFLAMMATORISK (NSAID) OG EN PROGESTOGEN FORBINDELSE, OG FREMGANGSMÅDER TIL FREMSTILLING HERAF | Int. application no. | EP2016051135 | Int. publication no. | WO2016116502 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|